fleroxacin and norfloxacin

fleroxacin has been researched along with norfloxacin in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	16 (37.21)	18.7374
1990's	18 (41.86)	18.2507
2000's	5 (11.63)	29.6817
2010's	4 (9.30)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Angehrn, P; Gmünder, H; Gubernator, K; Hubschwerlen, C; Kompis, I; Pflieger, P; Specklin, JL	1
Cohen, MA; Domagala, JM; Mailloux, GB; Roland, GE; Suto, MJ	1
Domagala, JM; Heifetz, CL; Hutt, MP; Mich, TF; Nichols, JB; Solomon, M; Worth, DF	1
Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M	1
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Bellman, K; Knegtel, RM; Settimo, L	1
Jones, RN	1
Hancock, RE; Young, M	1
Conejo, MC; García, I; Pascual, A; Perea, EJ	1
Boeckk, M; Borner, K; Deppermann, N; Höffken, G; Koeppe, P; Lode, H	1
Borsa-Lebas, F; Dhib, M; Fillastre, JP; Humbert, G; Leroy, A; Moulin, B	1
Felber, AM; Hohl, P	2
Aubert, G; Denis, M; Dorche, G; Loboguerrero, M; Lucht, F; Puech, C	1
Aoyama, H; Hirai, K; Hosaka, M; Irikura, T; Niwata, Y; Oomori, Y; Suzue, S	1
Fass, RJ; Helsel, VL	1
Clarke, AM; Zemcov, SJ	1
Habiyaremye, I; Vandepitte, J; Verbist, L	1
Braveny, I; Machka, K	1
Verbist, L	1
Claeys, G; Van den Abeele, AM; Verschraegen, G	1
Fabrig, J; Hof, H	1
Bremner, DA; Dickie, AS; Singh, KP	1
Braunsteiner, A; Herzog, C; Hohl, P; Paganoni, R	1
Fernandes, PB; Swanson, RN	1
Nagayama, A; Nakao, T; Taen, H	1
Griffiths, NM; Hirst, BH; Simmons, NL	1
Hendrickx, AG; Hummler, H; Richter, WF	1
Childs, S; Clark, J; Cox, CE; Fredericks, J; Hamrick, LC; Moon, JO; Pittman, W; Pizzuti, D; St Clair, P	1
Childs, SJ	1
Pummer, K	1
Ballesta, S; García, I; Pascual, A; Perea, EJ	1
Fabian, I; Gruss, T; Kletter, Y; Shalit, I; Weiss, K	1
Barbosa, J; Bergés, R; Sanz-Nebot, V	1
Chignell, CF; Martínez, L	1
Gomi, H; Hatanaka, K; Kawada, A; Matsuo, I	1
Bouquet, S; Couet, W; de Boer, AG; de Lange, EC; Delon, A; Marchand, S; van den Berg, D; van der Sandt, IC	1
Fukuda, H; Kawamura, Y	1
Fang, Z; Liu, X; Song, X	1
Kim, J; Ohtani, H; Sawada, Y; Tsujimoto, M	1
Alaboud, M; Bulatov, A; Korolev, D; Lebedinets, S; Moskvin, L; Osmolovskaya, O; Postnov, V; Vakh, C	1
Li, L; Lian, J; Lian, SQ; Wang, GR; Xue, YS; Yang, DZ	1

Reviews

1 review(s) available for fleroxacin and norfloxacin

Article	Year
Pharmacokinetics of quinolones in renal insufficiency. The Journal of antimicrobial chemotherapy, 1990, Volume: 26 Suppl B Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Glomerular Filtration Rate; Half-Life; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones	1990

Trials

3 trial(s) available for fleroxacin and norfloxacin

Article	Year
Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection. The American journal of medicine, 1993, Mar-22, Volume: 94, Issue:3A Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Fleroxacin; Humans; Male; Middle Aged; Norfloxacin; Prospective Studies; Treatment Outcome; Urinary Tract Infections	1993
Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections. The American journal of medicine, 1993, Mar-22, Volume: 94, Issue:3A Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Fleroxacin; Humans; Male; Middle Aged; Norfloxacin; Prospective Studies; Recurrence; Severity of Illness Index; Urinary Tract Infections	1993
Fleroxacin versus norfloxacin in the treatment of urinary tract infections: a multicenter, double-blind, prospective, randomized, comparative study. The American journal of medicine, 1993, Mar-22, Volume: 94, Issue:3A Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Fleroxacin; Humans; Male; Middle Aged; Norfloxacin; Prospective Studies; Superinfection; Treatment Outcome; Urinary Tract Infections	1993

Other Studies

39 other study(ies) available for fleroxacin and norfloxacin

Article	Year
Pyrimido[1,6-a]benzimidazoles: a new class of DNA gyrase inhibitors. Journal of medicinal chemistry, 1992, Apr-17, Volume: 35, Issue:8 Topics: Benzimidazoles; Enzyme Inhibitors; Pyrimidinones; Structure-Activity Relationship; Topoisomerase II Inhibitors	1992
Fluoroquinolones: relationships between structural variations, mammalian cell cytotoxicity, and antimicrobial activity. Journal of medicinal chemistry, 1992, Dec-11, Volume: 35, Issue:25 Topics: Animals; Anti-Infective Agents; Cricetinae; Cricetulus; Fluoroquinolones; Microbial Sensitivity Tests; Structure-Activity Relationship	1992
1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials. Journal of medicinal chemistry, 1988, Volume: 31, Issue:5 Topics: Animals; Anti-Bacterial Agents; Bacteria; Carboxylic Acids; Chemical Phenomena; Chemistry; Mice; Microbial Sensitivity Tests; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors	1988
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. Journal of medicinal chemistry, 1986, Volume: 29, Issue:3 Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors	1986
Predicting blood-brain barrier permeation from three-dimensional molecular structure. Journal of medicinal chemistry, 2000, Jun-01, Volume: 43, Issue:11 Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
In vitro evaluation of E-4695, a new fluoro-naphthyridine. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992, Volume: 11, Issue:2 Topics: Anti-Bacterial Agents; Azetidines; Bacteria; Ciprofloxacin; Drug Evaluation, Preclinical; Enoxacin; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Quinolones	1992
Fluoroquinolone supersusceptibility mediated by outer membrane protein OprH overexpression in Pseudomonas aeruginosa: evidence for involvement of a nonporin pathway. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:11 Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Cell Membrane; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Fleroxacin; Gene Expression; Norfloxacin; Porins; Pseudomonas aeruginosa	1992
Fluorometric and high-performance liquid chromatographic measurement of quinolone uptake by human neutrophils. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991, Volume: 10, Issue:11 Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fleroxacin; Fluorescence; Fluoroquinolones; Humans; Neutrophils; Norfloxacin; Ofloxacin; Quinolones	1991
Quinolone pharmacokinetics and metabolism. The Journal of antimicrobial chemotherapy, 1990, Volume: 26 Suppl B Topics: Administration, Oral; Anti-Infective Agents; Biological Availability; Biotransformation; Ciprofloxacin; Enoxacin; Fleroxacin; Half-Life; Humans; Metabolic Clearance Rate; Norfloxacin; Ofloxacin; Pefloxacin	1990
In vitro activity of fleroxacin against aerobic gram-positive bacteria including Corynebacterium jeikeium. Chemotherapy, 1990, Volume: 36, Issue:6 Topics: Bacteria, Aerobic; Ciprofloxacin; Corynebacterium; Fleroxacin; Gram-Positive Bacteria; Microbial Sensitivity Tests; Norfloxacin; Streptococcus pyogenes	1990
[Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin]. Pathologie-biologie, 1989, Volume: 37, Issue:8 Topics: Anti-Infective Agents; Ciprofloxacin; Citrobacter; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fleroxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pefloxacin; Pseudomonas aeruginosa; Serratia marcescens	1989
In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative. Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; Fleroxacin; Male; Mice; Mice, Inbred ICR; Norfloxacin; Ofloxacin; Oxazines; Pneumonia; Quinolines; Urinary Tract Infections	1986
In vitro activity of RO 23-6240 (AM-833): a new fluoroquinolone. Diagnostic microbiology and infectious disease, 1987, Volume: 6, Issue:4 Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Fleroxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin	1987
In vitro activity of the new 4-quinolone compound Ro 23-6240. European journal of clinical microbiology, 1987, Volume: 6, Issue:2 Topics: Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Fleroxacin; Gentamicins; Haemophilus influenzae; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Staphylococcus aureus	1987
[Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria]. Pathologie-biologie, 1987, Volume: 35, Issue:5 Pt 2 Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica	1987
Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative. European journal of clinical microbiology, 1987, Volume: 6, Issue:4 Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enterobacteriaceae; Enterococcus faecalis; Fleroxacin; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Staphylococcus	1987
Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone. The Journal of antimicrobial chemotherapy, 1987, Volume: 20, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines	1987
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:1 Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin	1988
Comparative activities of norfloxacin and fleroxacin in experimental infections due to Salmonella typhimurium and Escherichia coli. The Journal of antimicrobial chemotherapy, 1988, Volume: 22 Suppl D Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Fleroxacin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Norfloxacin; Salmonella Infections, Animal; Salmonella typhimurium	1988
In-vitro activity of fleroxacin compared with three other quinolones. The Journal of antimicrobial chemotherapy, 1988, Volume: 22 Suppl D Topics: Anti-Infective Agents; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin	1988
Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxacin. The Journal of antimicrobial chemotherapy, 1988, Volume: 22 Suppl D Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Fleroxacin; Microbial Sensitivity Tests; Norfloxacin	1988
Effect of method, medium, pH and inoculum on the in-vitro antibacterial activities of fleroxacin and norfloxacin. The Journal of antimicrobial chemotherapy, 1988, Volume: 22 Suppl D Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Culture Media; Fleroxacin; Hydrogen-Ion Concentration; Methods; Norfloxacin	1988
Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies. Drugs under experimental and clinical research, 1988, Volume: 14, Issue:6 Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones	1988
In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis. Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:11 Topics: Anti-Infective Agents; Chlamydia trachomatis; Ciprofloxacin; Doxycycline; Fleroxacin; Fluoroquinolones; Minocycline; Norfloxacin; Ofloxacin; Quinolones	1988
Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway? The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:2 Topics: Biological Transport; Carbon Radioisotopes; Cells, Cultured; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Humans; Intestinal Mucosa; Norfloxacin; Ofloxacin; Pefloxacin; Quinolizines	1994
Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis). Toxicology and applied pharmacology, 1993, Volume: 122, Issue:1 Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Embryo, Mammalian; Female; Fleroxacin; Fluoroquinolones; Macaca fascicularis; Norfloxacin; Pregnancy; Pregnancy, Animal; Quinolones	1993
[Uptake of 5 fluoroquinolones into human polymorphonuclear cells]. Enfermedades infecciosas y microbiologia clinica, 1996, Volume: 14, Issue:8 Topics: Anti-Infective Agents; Biological Transport; Fleroxacin; Fluorometry; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Levofloxacin; Neutrophils; Norfloxacin; Ofloxacin; Quinolones; Temperature	1996
Enhanced hematopoiesis in sublethally irradiated mice treated with various quinolones. European journal of haematology, 1997, Volume: 58, Issue:2 Topics: Animals; Anti-Infective Agents; Bone Marrow; Cells, Cultured; Ciprofloxacin; Cobalt Radioisotopes; Colony-Forming Units Assay; Culture Media, Conditioned; Fleroxacin; Fluoroquinolones; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Hemoglobins; Interleukin-3; Leukocyte Count; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Norfloxacin; Ofloxacin; Quinolones; Whole-Body Irradiation	1997
Retention behaviour of quinolone derivatives in high-performance liquid chromatography. Effect of pH and evaluation of ionization constants. Journal of chromatography. A, 1998, Oct-09, Volume: 823, Issue:1-2 Topics: Acetonitriles; Anti-Infective Agents; Chromatography, High Pressure Liquid; Enoxacin; Fleroxacin; Fluoroquinolones; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Osmolar Concentration; Potentiometry; Quinolizines; Quinolones; Thermodynamics; Water	1998
Photocleavage of DNA by the fluoroquinolone antibacterials. Journal of photochemistry and photobiology. B, Biology, 1998, Aug-21, Volume: 45, Issue:1 Topics: Anti-Infective Agents; DNA Damage; Enoxacin; Fleroxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Photolysis; Plasmids; Quinolones; Structure-Activity Relationship; Ultraviolet Rays	1998
In vitro phototoxicity of new quinolones: production of active oxygen species and photosensitized lipid peroxidation. Photodermatology, photoimmunology & photomedicine, 1999, Volume: 15, Issue:6 Topics: Anti-Infective Agents; Ciprofloxacin; Dermatitis, Phototoxic; DNA Damage; Fleroxacin; Fluoroquinolones; Humans; Lipid Peroxidation; Norfloxacin; Ofloxacin; Quinolones; Reactive Oxygen Species; Squalene; Time Factors; Ultraviolet Rays	1999
In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2000, Volume: 12, Issue:2 Topics: 4-Quinolones; Animals; Anti-Infective Agents; Antitubercular Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Brain; Cell Line; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Infusions, Intra-Arterial; Kidney; Mice; Mice, Inbred Strains; Mice, Knockout; Microdialysis; Norfloxacin; Pefloxacin; Recombinant Proteins; Rhodamine 123; Swine; Tissue Distribution; Transfection	2000
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration]. The Japanese journal of antibiotics, 2002, Volume: 55, Issue:3 Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins	2002
[Study on the DNA gyrA gene mutation with resistance to fluoroquinolones in Staphylococcus aureus isolated from patients]. Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 2000, Volume: 31, Issue:1 Topics: Anti-Infective Agents; DNA Gyrase; Drug Resistance, Bacterial; Fleroxacin; Fluoroquinolones; Humans; Naphthyridines; Norfloxacin; Point Mutation; Staphylococcus aureus	2000
Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents. Drug metabolism and pharmacokinetics, 2009, Volume: 24, Issue:2 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Diclofenac; Dioxolanes; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Male; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Phenylacetates; Piperazines; Receptors, GABA-A; Seizures	2009
An automated magnetic dispersive micro-solid phase extraction in a fluidized reactor for the determination of fluoroquinolones in baby food samples. Analytica chimica acta, 2018, Feb-25, Volume: 1001 Topics: Animals; Anti-Bacterial Agents; Cattle; Chickens; Chromatography, High Pressure Liquid; Equipment Design; Fleroxacin; Flow Injection Analysis; Fluoroquinolones; Food Contamination; Humans; Infant; Infant Food; Limit of Detection; Magnetics; Meat; Norfloxacin; Ofloxacin; Solid Phase Microextraction; Turkey	2018
Investigation of binding between fluoroquinolones and pepsin by fluorescence spectroscopy and molecular simulation. Luminescence : the journal of biological and chemical luminescence, 2019, Volume: 34, Issue:6 Topics: Anti-Bacterial Agents; Fleroxacin; Fluorescence; Fluoroquinolones; Kinetics; Molecular Conformation; Molecular Docking Simulation; Norfloxacin; Pepsin A; Protein Binding; Spectrometry, Fluorescence	2019